We have updated our privacy policy. If you have any question, contact us at privacy@scicrunch.org. Dismiss and don't show again

Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Caspase 8 inhibits programmed necrosis by processing CYLD.

Nature cell biology | Oct 30, 2011

Caspase 8 initiates apoptosis downstream of TNF death receptors by undergoing autocleavage and processing the executioner caspase 3 (ref. 1). However, the dominant function of caspase 8 is to transmit a pro-survival signal that suppresses programmed necrosis (or necroptosis) mediated by RIPK1 and RIPK3 (refs 2-6) during embryogenesis and haematopoiesis(7-9). Suppression of necrotic cell death by caspase 8 requires its catalytic activity but not the autocleavage essential for apoptosis(10); however, the key substrate processed by caspase 8 to block necrosis has been elusive. A key substrate must meet three criteria: it must be essential for programmed necrosis; it must be cleaved by caspase 8 in situations where caspase 8 is blocking necrosis; and mutation of the caspase 8 processing site on the substrate should convert a pro-survival response to necrotic death without the need for caspase 8 inhibition. We now identify CYLD as a substrate for caspase 8 that satisfies these criteria. Following TNF stimulation, caspase 8 cleaves CYLD to generate a survival signal. In contrast, loss of caspase 8 prevented CYLD degradation, resulting in necrotic death. A CYLD substitution mutation at Asp 215 that cannot be cleaved by caspase 8 switches cell survival to necrotic cell death in response to TNF.

Pubmed ID: 22037414 RIS Download

Mesh terms: Animals | Caspase 8 | Cell Survival | Cells, Cultured | Embryo, Mammalian | Female | Fibroblasts | HEK293 Cells | Humans | Jurkat Cells | Mice | Necrosis | Protein Processing, Post-Translational | Signal Transduction | Tumor Suppressor Proteins

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

Associated grants

  • Agency: NIAID NIH HHS, Id: AI44828
  • Agency: NIAID NIH HHS, Id: R01 AI052417
  • Agency: NIDDK NIH HHS, Id: P30 DK043351
  • Agency: NIAID NIH HHS, Id: AI052417
  • Agency: NIGMS NIH HHS, Id: R01 GM052735-11
  • Agency: NIAID NIH HHS, Id: R01 AI044828-13
  • Agency: NIAID NIH HHS, Id: R56 AI052417
  • Agency: NIAID NIH HHS, Id: R01 AI044828
  • Agency: NIGMS NIH HHS, Id: R01 GM052735

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

We have not found any resources mentioned in this publication.